Mark J Drish is listed as a director on 4 SEC Form D filings by 2 issuers between Jan 2010 and Nov 2017: CORVIDA MEDICAL, INC. (Needham, MA — other health care — 2016; $12.9M reported sold to 113 investors) and Terpenoid Therapeutics, Inc. (Coralville, IA — pharmaceuticals — 2010–2017; $950K reported sold to 14 investors).
What this means 2 separate companies raised money with this person listed as director, over about 7 years. Across those companies the filings report $13.9M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 court cases matching the name, 2 bankruptcy cases matching the name listed in Key records below.
What this means 5 records came back, including 2 court cases still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Mark J Drish and found 7 differences, 2 worth asking the sponsor about: Form D filed 636 days after the first sale; Form D filed 2,014 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.